Related Experiment Videos

Collaborative quality improvement to promote evidence based surfactant for preterm infants: a cluster randomised

Jeffrey D Horbar1, Joseph H Carpenter, Jeffrey Buzas

  • 1Vermont Oxford Network, 33 Kilburn Street, Burlington, VT 05401, USA. horbar@vtoxford.org

BMJ (Clinical Research Ed.)
|October 30, 2004
PubMed

Insights

A quality improvement intervention significantly improved evidence-based surfactant treatment for preterm infants, ensuring timely administration. This initiative enhanced surfactant delivery practices without impacting infant mortality or pneumothorax rates.

Area of Science:

  • Neonatal Medicine
  • Quality Improvement Science
  • Evidence-Based Practice

Background:

  • Preterm infants (23-29 weeks gestation) require timely surfactant treatment for respiratory distress syndrome.
  • Variability exists in the administration of evidence-based surfactant therapy in neonatal intensive care units.
  • Optimizing surfactant treatment is crucial for improving outcomes in extremely preterm infants.

Purpose of the Study:

  • To evaluate a multifaceted collaborative quality improvement intervention aimed at promoting evidence-based surfactant treatment.
  • To assess the impact of the intervention on the timing and process of surfactant administration in preterm infants.
  • To determine if the intervention influenced clinical outcomes such as mortality and pneumothorax.

Main Methods:

  • A cluster randomized controlled trial involving 114 neonatal intensive care units and 6039 infants (23-29 weeks gestation).
  • The intervention included audit and feedback, evidence reviews, training workshops, and ongoing faculty support.
  • Process measures focused on surfactant delivery timing (delivery room, >2 hours post-birth), and clinical outcomes included mortality and pneumothorax.

Main Results:

  • Infants in intervention hospitals were significantly more likely to receive surfactant in the delivery room (aOR 5.38).
  • The intervention reduced the likelihood of delayed surfactant administration (>2 hours post-birth) (aOR 0.35) and decreased median time to first dose (21 vs. 78 minutes).
  • No significant differences were observed in mortality before discharge or pneumothorax rates between groups.

Conclusions:

  • A multifaceted quality improvement intervention effectively changed healthcare professional behavior.
  • The intervention successfully promoted evidence-based surfactant treatment practices for preterm infants.
  • The study demonstrates the feasibility and impact of collaborative quality improvement in neonatal care.
Abstract